Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
The quest for a red blood cell substitute
D. H. Ingbar
Pulmonary, Allergy, Critical Care and Sleep Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The quest for a red blood cell substitute'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Critically Ill Patients
100%
Hematocrit
100%
Red Blood Cell Substitute
100%
Artificial Blood Substitutes
80%
Oxygen Transport
60%
Leech
40%
Anemia
40%
ICU Patients
40%
Respiratory Failure
40%
Oxygen Delivery
40%
Oxygen Consumption
40%
Blood Substitutes
40%
Starling
40%
Inflammation
20%
Oxygen Radicals
20%
Bleeding
20%
Multiple Organ Failure
20%
Christmas
20%
Hemoglobin
20%
Clinical Benefit
20%
Potential Toxicity
20%
Multiple Stressors
20%
Crystalloid
20%
Polymerized
20%
Intensive Care
20%
Patient Needs
20%
Tumor Therapy
20%
Albumin
20%
Human Trials
20%
Red Blood Cell Transfusion
20%
Cardiac Dysfunction
20%
Intravascular Volume
20%
Toxicity Study
20%
Severe Anemia
20%
Patient-led
20%
Tissue Oxygen Delivery
20%
Credence
20%
Long Half-life
20%
Banking System
20%
RBC Transfusion
20%
Ghosts
20%
Perfluorocarbon
20%
Direct Toxicity
20%
Physician Response
20%
Safe Use
20%
Delivery Properties
20%
Oxygen Capacity
20%
Chemosensitizer
20%
Blood Banking
20%
Jehovah's Witness
20%
Ischemic Disease
20%
Microvascular Circulation
20%
Optimal Hematocrit
20%
Acute Anemia
20%
Accident Site
20%
Acid Buffering
20%
Liposome-encapsulated Hemoglobin
20%
Carbon Dioxide Transport
20%
Oxygen Transport System
20%
Radiation Sensitizer
20%
Clinical Outcomes
20%
Clinical Situation
20%
Physiologist
20%
Hemoglobin Solutions
20%
Oxygen Carries
20%
Nursing and Health Professions
Blood Substitute
100%
Hematocrit
100%
Artificial Blood
66%
Anemia
66%
Half Life Time
33%
Respiratory Failure
33%
Multiple Organ Failure
16%
Radiosensitizing Agent
16%
Inflammation
16%
Clinical Outcome
16%
Food and Drug Administration
16%
Physiologist
16%
Liposome
16%
Intensive Care
16%
Cancer Therapy
16%
Erythrocyte Transfusion
16%
Ischemia
16%
Ciclonicate
16%
Fluorocarbon
16%
Oxygen Radical
16%
Albumin
16%
Carbon Dioxide
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Substitute
100%
Artificial Blood
66%
Anemia
66%
Starling
33%
Respiratory Failure
33%
Clinical Trial
16%
Chemotherapy
16%
Radiosensitizing Agent
16%
Ischemia
16%
Multiple Organ Failure
16%
Liposome
16%
Oxygen Radical
16%
Ciclonicate
16%
Fluorocarbon
16%
Inflammation
16%
Neoplasm
16%
Albumin
16%
Carbon Dioxide
16%
Diseases
16%